DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/r97hdz/rna) has announced the addition of the "RNA Analysis/Transcriptomics Market by Technology, by Application, by End-User - Global Forecast to 2019" report to their offering.
The global transcriptomics market was valued at $1,743.2 million in 2013 and is expected to reach at $3,773.0 million by 2019, at a CAGR of 13.7% during the forecast period of 2014 to 2019
This market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines.
However, lack of skilled professionals in the transcriptomics field and lack of efficient bioinformatics and data analysis tools to analyze enormous data generated from the high-throughput sequencing technologies expected to restrain the growth of this market to a certain extent
The global market covers transcriptomic technologies, applications, and end-users. The RNA Analysis technologies market is segmented as microarray, PCR, sequencing technologies which include Sanger sequencing and NGS, and RNAi gene silencing technology. Each of these technologies market is further sub-segmented as reagents, instruments and software. The applications of RNA analysis covered under the scope of this report are clinical diagnostics, drug discovery, and toxicogenomics.
The end-users of RNA analysis are pharmaceutical and biotechnology companies, academic research and government institutes, and hospitals and diagnostic centers. This report also discusses the key market drivers, restraints, opportunities, challenges, and trends in the global transcriptomics market and its submarkets. The global market is divided into four major geographies, namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW).
North America holds the largest share of the global transcriptomics market. However, in the forthcoming years, developing regions such as Asia-Pacific (Japan, China, and India) and Latin America are expected to form new revenue-generating pockets for the market players. Economic developments and growing government funding to support new product developments are the key factors driving the growth of market in developing regions.
- Clinical Diagnostics
- Drug Discovery
- Academic Research
- Biotech Companies
The prominent players in the market are:
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
- GE Healthcare
- Illumina Inc.
- F. Hoffmann-La Roche Ltd.
- Sigma Aldrich
- Thermofisher Scientific Inc.
For more information visit http://www.researchandmarkets.com/research/r97hdz/rna